CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing Β-Catenin Ubiquitination

Hongliang Liu,Junwen Hu,Hua Pan,Dilai Luo,Mingwen Huang,Wei Xu
DOI: https://doi.org/10.1007/s10620-017-4855-9
2017-01-01
Digestive Diseases and Sciences
Abstract:Increasing evidence has suggested that E3 Ubiquitin Ligase CSN5 is a newly characterized oncogene involved in various types of cancer. Scavenger receptor class A member 5 (SCARA5) is an important regulator of biological processes in cancer cells. However, the roles and relationship of CSN5 and SCARA5 in hepatocellular carcinoma (HCC) remain unclear.
What problem does this paper attempt to address?